These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 16750885)

  • 1. Leishmune vaccine: the newest tool for prevention and control of canine visceral leishmaniosis and its potential as a transmission-blocking vaccine.
    Dantas-Torres F
    Vet Parasitol; 2006 Oct; 141(1-2):1-8. PubMed ID: 16750885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine.
    Saraiva EM; de Figueiredo Barbosa A; Santos FN; Borja-Cabrera GP; Nico D; Souza LO; de Oliveira Mendes-Aguiar C; de Souza EP; Fampa P; Parra LE; Menz I; Dias JG; de Oliveira SM; Palatnik-de-Sousa CB
    Vaccine; 2006 Mar; 24(13):2423-31. PubMed ID: 16386824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs.
    Nogueira FS; Moreira MA; Borja-Cabrera GP; Santos FN; Menz I; Parra LE; Xu Z; Chu HJ; Palatnik-de-Sousa CB; Luvizotto MC
    Vaccine; 2005 Sep; 23(40):4805-10. PubMed ID: 16011864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Search for a vaccine against leishmaniasis].
    Poot J
    Tijdschr Diergeneeskd; 2006 Oct; 131(19):694-5. PubMed ID: 17052076
    [No Abstract]   [Full Text] [Related]  

  • 6. Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas.
    Palatnik-de-Sousa CB; Silva-Antunes I; Morgado Ade A; Menz I; Palatnik M; Lavor C
    Vaccine; 2009 Jun; 27(27):3505-12. PubMed ID: 19464528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals.
    Gradoni L; Foglia Manzillo V; Pagano A; Piantedosi D; De Luna R; Gramiccia M; Scalone A; Di Muccio T; Oliva G
    Vaccine; 2005 Nov; 23(45):5245-51. PubMed ID: 16054272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis.
    Reis AB; Giunchetti RC; Carrillo E; Martins-Filho OA; Moreno J
    Trends Parasitol; 2010 Jul; 26(7):341-9. PubMed ID: 20488751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine.
    Palatnik-de-Sousa CB; Barbosa Ade F; Oliveira SM; Nico D; Bernardo RR; Santos WR; Rodrigues MM; Soares I; Borja-Cabrera GP
    Expert Rev Vaccines; 2008 Aug; 7(6):833-51. PubMed ID: 18665780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
    Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J
    Vaccine; 2007 Nov; 25(46):7962-71. PubMed ID: 17942199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished CD4+/CD25+ T cell and increased IFN-gamma levels occur in dogs vaccinated with Leishmune in an endemic area for visceral leishmaniasis.
    de Lima VM; Ikeda FA; Rossi CN; Feitosa MM; Vasconcelos RO; Nunes CM; Goto H
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):296-302. PubMed ID: 20132994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of Deltamethrine-impregnated collars Scalibor in the prevention of canine leishmaniasis in the area of Tunis].
    Aoun K; Chouihi E; Boufaden I; Mahmoud R; Bouratbine A; Bedoui K
    Arch Inst Pasteur Tunis; 2008; 85(1-4):63-8. PubMed ID: 19469417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine leishmaniasis.
    Alvar J; Cañavate C; Molina R; Moreno J; Nieto J
    Adv Parasitol; 2004; 57():1-88. PubMed ID: 15504537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
    Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
    Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 65% permethrin spot-on and deltamethrin-impregnated collars for canine Leishmania infantum infection prevention.
    Ferroglio E; Poggi M; Trisciuoglio A
    Zoonoses Public Health; 2008 Apr; 55(3):145-8. PubMed ID: 18331517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine Leishmania vaccines: still a long way to go.
    Gradoni L
    Vet Parasitol; 2015 Feb; 208(1-2):94-100. PubMed ID: 25620293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.
    Ramos I; Alonso A; Marcen JM; Peris A; Castillo JA; Colmenares M; Larraga V
    Vaccine; 2008 Jan; 26(3):333-44. PubMed ID: 18093705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of anti-Leishmania (Leishmania) chagasi IgG titers detected by flow cytometry to distinguish infected from vaccinated dogs.
    de Andrade RA; Reis AB; Gontijo CM; Braga LB; Rocha RD; Araújo MS; Vianna LR; Martins-Filho OA
    Vet Immunol Immunopathol; 2007 Mar; 116(1-2):85-97. PubMed ID: 17287029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part one.
    Baneth G; Koutinas AF; Solano-Gallego L; Bourdeau P; Ferrer L
    Trends Parasitol; 2008 Jul; 24(7):324-30. PubMed ID: 18514028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenicity of a whole parasite vaccine as promising candidate against canine leishmaniasis.
    Giunchetti RC; Reis AB; da Silveira-Lemos D; Martins-Filho OA; Corrêa-Oliveira R; Bethony J; Vale AM; da Silva Quetz J; Bueno LL; França-Silva JC; Nascimento E; Mayrink W; Fujiwara RT
    Res Vet Sci; 2008 Aug; 85(1):106-12. PubMed ID: 17950391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.